Patent · US Active

Compounds that induce degradation of anti-apoptotic Bcl-2 family proteins and the uses thereof

US10807977B2 · kind B2 · utility

2Cited by
25References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 21, 2017
Grant dateOct 20, 2020
Priority date
Expiry dateApr 21, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides compositions and methods for selectively killing senescent cells, wherein the composition comprises a compound of Formula (I) or a compound of Formula (II). The selective killing of senescent cells may delay aging and/or treat age-related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.